🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Clinically Significant Prostate Cancer

Transperineal Versus Transrectal Cognitive Fusion Prostate Biopsy NCT07710807NA1 site📍 Ankara Ankara Etlik City Hospital · Tests: Transrectal Cognitive Fusion Prostate Biopsy, Transperineal Cognitive Fusion Prostate Biopsy Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer NCT07492927n/a10 sites📍 Chicago📍 Lanzhou📍 Yinchuan Xijing Hospital INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis NCT07398690NA1 site📍 Seoul In Gab Jeong, MD · Tests: Diagnostic Procedure, Diagnostic Procedure Validation of a Machine Learning Model Based on MR for the Prediction of Prostate Cancer NCT06773598n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology NCT07432360n/a1 site📍 São Paulo Virdx, Inc. Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial NCT06303622NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: MRI-USG fusion approach, Cognitive-guided approach The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA) NCT06867588NA1 site📍 Brussels Jules Bordet Institute · Tests: PSMA PET Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer NCT07553780n/a9 sites📍 Lanzhou📍 Yinchuan📍 Xining Xijing Hospital Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial NCT07164027EARLY Phase 11 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biopsy of Prostate, Biospecimen Collection, Computed Tomography, Flotufolastat F-18 Gallium, Positron Emission Tomograp… The Development and Validation of MRI-AI-based Predictive Models for csPCa NCT06842264n/a1 site📍 Beijing Peking University First Hospital Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer NCT07531329n/a9 sites📍 Lanzhou📍 Yinchuan📍 Xining Xijing Hospital · Tests: [⁶⁸Ga]Ga-PSMA PET/CT with Delayed Pelvic PET-Only Acquisition Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer. NCT06305390Phase 21 site📍 Milan IRCCS San Raffaele · Tests: PET/MRI Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance NCT07168616n/a10 sites📍 Istanbul📍 Ankara📍 Diyarbakır Istanbul University - Cerrahpasa · Tests: Ga-68 PSMA11 PET/CT Ipsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis NCT07795723NA1 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: MRI/US Cognitive Fusion Targeted Biopsy Plus Ipsilateral Systematic Biopsy, MRI/US Cognitive Fusion Targeted Biopsy Plu… POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions NCT07220720Phase 21 site📍 Jacksonville University of Florida · Tests: Flotufolastat F 18 Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System NCT07109427NA1 site📍 St Louis Washington University School of Medicine · Tests: Annual PSA Health Maintenance Reminder Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction NCT07614256n/a1 site📍 Liuzhou Guangxi Medical University · Tests: No Intervention: Observational Cohort Radical Prostatectomy Without Prior Biopsy NCT07819760NA1 site📍 Moscow Botkin Hospital · Tests: Transperineal Fusion-Targeted Prostate Biopsy With Intraoperative Frozen Section Examination, Robot-Assisted Radical Pr… Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer NCT06579911NA1 site📍 Salzburg Salzburger Landeskliniken · Tests: High-frequency micro-ultrasound target biopsy, conventional Multiparametric MRT target biopsy Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions NCT06774781n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy